4.7 Review

Pharmacological and Molecular Insight on the Cardioprotective Role of Apigenin

期刊

NUTRIENTS
卷 15, 期 2, 页码 -

出版社

MDPI
DOI: 10.3390/nu15020385

关键词

antioxidants; anti-inflammatory; apigenin; cardioprotection; flavonoid; heart; myocardial protection; polyphenolic; polyphenols

向作者/读者索取更多资源

Apigenin, a dietary flavonoid, has antioxidant, anti-inflammatory, anticancer, and antibacterial properties. It has shown potential therapeutic effects in the treatment of cardiovascular diseases such as atherosclerosis, stroke, hypertension, myocardial injury, and diabetic cardiomyopathy. This review focuses on the pharmacological mechanisms, therapeutic uses, and potential applications of apigenin in the treatment of cardiovascular disorders. Further research is needed to establish its safety and efficacy and explore its potential as a nutraceutical and therapeutic agent.
Apigenin is a naturally occurring dietary flavonoid found abundantly in fruits and vegetables. It possesses a wide range of biological properties that exert antioxidant, anti-inflammatory, anticancer, and antibacterial effects. These effects have been reported to be beneficial in the treatment of atherosclerosis, stroke, hypertension, ischemia/reperfusion-induced myocardial injury, and diabetic cardiomyopathy, and provide protection against drug-induced cardiotoxicity. These potential therapeutic effects advocate the exploration of the cardioprotective actions of apigenin. This review focuses on apigenin, and the possible pharmacological mechanisms involved in the protection against cardiovascular diseases. We further discuss its therapeutic uses and highlight its potential applications in the treatment of various cardiovascular disorders. Apigenin displays encouraging results, which may have implications in the development of novel strategies for the treatment of cardiovascular diseases. With the commercial availability of apigenin as a dietary supplement, the outcomes of preclinical studies may provide the investigational basis for future translational strategies evaluating the potential of apigenin in the treatment of cardiovascular disorders. Further preclinical and clinical investigations are required to characterize the safety and efficacy of apigenin and establish it as a nutraceutical as well as a therapeutic agent to be used alone or as an adjuvant with current drugs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据